Topics of Interest: Alzheimer's
Scientists pinpoint gene influencing age-at-onset of Alzheimer's, Parkinson's
October 21, 2003
Scientists at Duke University Medical Center have located a gene on chromosome 10 that they believe influences the age-at-onset of Alzheimer's disease and Parkinson's disease. Using a novel method to match the genes of people...
NIA and Alzheimer's Association Join Forces Promoting Major AD Genetics Initiative
July 22, 2003
The National Institute on Aging (NIA) is greatly advancing the search for genes involved in Alzheimer's disease (AD) with acceleration of the AD Genetics Initiative. Joined by the Alzheimer's Association, the NIA is stepping up the...
High homocysteine levels may double risk of dementia, Alzheimer's disease, new report suggests
February 13, 2002
People with elevated levels of homocysteine in the blood had nearly double the risk of developing Alzheimer's disease (AD), according to a new report from scientists at Boston University. The findings, in a group of people...
"Use it or lose it?" study suggests mentally stimulating activities may reduce Alzheimer's risk
February 12, 2002
In recent years, many of us have come to believe that doing crossword puzzles or playing cards might ward off a decline in memory or help us maintain "brainpower" as we age. Now, a new study suggests there might be some truth to...
Alzheimer's disease clinical trials expanded, expedited
September 20, 2001
As part of intensifying efforts to expand and expedite the search for Alzheimer's disease (AD) treatments, the National Institute on Aging (NIA) has awarded $54 million to support the Alzheimer's Disease Cooperative Study (ADCS), a...
New study links head injury, severity of injury, with Alzheimer's disease
October 23, 2000
A new analysis of head injuries among World War II veterans links serious head injury in early adulthood with Alzheimer's disease (AD) in later life. The study, by researchers at Duke University and the National Institute on Aging (NIA...
Nasal Alzheimer's vaccine successfully tested in mice
October 15, 2000
Nasal administration of synthetic beta amyloid peptide reduces potentially damaging Alzheimer's disease-like plaques in the brains of test mice and may one day be tested in clinical trials for its ability to vaccinate against plaque...
NIA to study COX-2 inhibitor, other NSAID as new treatment for Alzheimer's disease
February 7, 2000
The National Institute on Aging (NIA) is launching a clinical trial to determine whether treatment with certain nonsteroidal anti-inflammatory drugs (NSAIDs) will slow cognitive and clinical decline in patients with Alzheimer's disease...
Low-dose prednisone found ineffective against Alzheimer's disease; researchers continue to look at NSAIDs, other drugs
February 7, 2000
A low-dose regimen of the steroid prednisone, an anti-inflammatory drug, is not effective in the treatment of Alzheimer's disease (AD), according to findings from a new clinical trial. The report, one of the first from a number of...
"Untangling" tau: New mouse model shows key feature of Alzheimer's disease
November 23, 1999
Scientists have succeeded in producing a hallmark of Alzheimer's disease in a laboratory animal model. The much-anticipated transgenic mouse model is genetically-engineered with the human gene coding for a form of the brain protein tau...